A simple litmus test for aldehyde oxidase metabolism of heteroarenes

Journal of Medicinal Chemistry

Volumn 57, Issue 4, 2014, Pages 1616-1620

  O'Hara, Fionn ^a   Burns, Aaron C ^b   Collins, Michael R ^b   Dalvie, Deepak ^b   Ornelas, Martha A ^b   Vaz, Alfin D N ^b   Fujiwara, Yuta ^a   Baran, Phil S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE OXIDASE; AROMATIC AZAHETEROCYCLIC DRUG; AROMATIC COMPOUND; BIS[[(DIFLUOROMETHYL)SULFINYL]OXY]ZINC; UNCLASSIFIED DRUG; ZINC DERIVATIVE;

ARTICLE; BIOAVAILABILITY; BIOTRANSFORMATION; CRYSTAL STRUCTURE; DRUG METABOLISM; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LITMUS TEST; OXIDATION; PROBABILITY;

ALDEHYDE OXIDASE; HYDROCARBONS;

EID: 84896891098     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm4017976     Document Type: Article

References (28)

1. Gleeson, M. P.; Hersey, A.; Montanari, D.; Overington, J. Probing the links between in vitro potency, ADMET and physicochemical parameters Nature Rev. Drug. Discovery 2011, 10, 197-208
2. Leeson, P. D.; Empfield, J. R. Reducing the risk of drug attrition associated with physicochemical properties Annu. Rep. Med. Chem. 2010, 4, 393-407
3. Pryde, D. C.; Dalvie, D.; Hu, Q.; Jones, P.; Obach, R. S.; Tran, T.-D. Aldehyde oxidase: an enzyme of emerging importance in drug discovery J. Med. Chem. 2010, 53, 8441-8460
4. Garattini, E.; Terao, M. Increasing recognition of the importance of aldehyde oxidase in drug development and discovery Drug. Metab. Rev. 2011, 43, 374-386
5. Garattini, E.; Terao, M. The role of aldehyde oxidase in drug metabolism Expert Opin. Drug Metab. Toxicol. 2012, 8, 487-503
6. Garattini, E.; Terao, M. Aldehyde oxidase and its importance in novel drug discovery: present and future challenges Expert Opin. Drug Discovery 2013, 8, 641-654
7. St. Jean, D. J.; Fotsch, C. Mitigating heterocycle metabolism in drug discovery J. Med. Chem. 2012, 55, 6002-6020
8. Hutzler, J. M.; Obach, R. S.; Dalvie, D.; Zientek, M. A. Strategies for a comprehensive understanding of metabolism by aldehyde oxidase Expert Opin. Drug Metab. Toxicol. 2013, 9, 153-168
9. Kaye, B.; Rance, D. J.; Waring, L. Oxidative metabolism of carbazeran in vitro by liver cytosol of baboon and man Xenobiotica 1985, 15, 237-242
10. Diamond, S.; Boer, J.; Maduskuie, T. P.; Falahatpisheh, N.; Li, Y.; Yeleswaram, S. Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications Drug Metab. Dispos. 2010, 38, 1277-1285
11. Lewis, D. F. V. On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism Biochem. Pharmacol. 2000, 60, 293-306
12. de Groot, M. J. Designing better drugs: predicting cytochrome P450 metabolism Drug Discovery Today 2006, 11, 601-606
13. Ekins, S.; de Groot, M. J.; Jones, J. P. Pharmacophore and three-dimensional quantitative structure-activity relationship methods for modeling cytochrome P450 active sites Drug Metab. Dispos. 2001, 29, 936-944
14. Cruciani, G.; Carosati, E.; De Boeck, B.; Ethirajulu, K.; Mackie, C.; Howe, T.; Vianello, R. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist J. Med. Chem. 2005, 48, 6970-6979
15. Torres, R. A.; Korzekwa, K. R.; McMasters, D. R.; Fandozzi, C. M.; Jones, J. P. Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase J. Med. Chem. 2007, 50, 4642-4647
16. Dastmalchi, S.; Hamzeh-Mivehrod, M. Molecular modelling of human aldehyde oxidase and the identification of the key interactions in the enzyme-substrate complex Daru, J. Fac. Pharm., Tehran Univ. Med. Sci. 2005, 13, 82-93
17. Angelino, S. A. G. F.; van Veldhuizen, A.; Buurman, D. J.; van der Plas, H. C. Covalent amination of 1-alkyl- and 1-aryl-3-carbamoylpyridinium chlorides as "model" for enzymic activity of rabbit liver aldehyde oxidase Tetrahedron 1984, 40, 433-439
18. Jones, J. P.; Korzekwa, K. R. Predicting intrinsic clearance for drugs and drug candidates metabolized by aldehyde oxidase Mol. Pharmaceutics 2013, 10, 1262-1268
19. Coelho, C.; Mahro, M.; Trincão, J.; Carvalho, A. T. P.; Ramos, M. J.; Terao, M.; Garattini, E.; Leimkühler, S.; Romão, M. The first mammalian aldehyde oxidase crystal structure: insights into substrate specificity J. Biol. Chem. 2012, 287, 40690-40702
20. Kitamura, S.; Sugihara, K.; Ohta, S. Drug-metabolizing ability of molybdenum hydroxylases Drug Metab. Pharmacokinet. 2006, 21, 83-98
21. Alfaro, J. F.; Jones, J. P. Studies on the mechanism of aldehyde oxidase and xanthine oxidase J. Org. Chem. 2008, 73, 9469-9472
22. Pryde, D. C.; Tran, T.-D.; Jones, P.; Duckworth, J.; Howard, M.; Gardner, I.; Hyland, R.; Webster, R.; Wenham, T.; Bagal, S.; Omoto, K.; Schneider, R. P.; Lin, J. Medicinal chemistry approaches to avoid aldehyde oxidase metabolism Bioorg. Med. Chem. Lett. 2012, 22, 2856-2860
23. O'Hara, F.; Blackmond, D. G.; Baran, P. S. Radical-based regioselective C-H functionalization of electron-deficient heteroarenes: scope, tunability, and predictability J. Am. Chem. Soc. 2013, 135, 12122-12134
24. Fujiwara, Y.; Dixon, J. A.; Rodriguez, R. A.; Baxter, R. D.; Dixon, D. D.; Collins, M. R.; Blackmond, D. G.; Baran, P. S. A new reagent for direct difluoromethylation J. Am. Chem. Soc. 2012, 134, 1494-1497
25. Dalvie, D.; Sun, H.; Xiang, C.; Hu, Q.; Jiang, Y.; Kang, P. Effect of structural variation on aldehyde oxidase-catalyzed oxidation of zoniporide Drug Metab. Dispos. 2012, 40, 1575-1587
26. Linton, A.; Kang, P.; Ornelas, M.; Kephart, S.; Hu, Q.; Pairish, M.; Jiang, Y.; Guo, C. Systematic structure modifications of imidazo[1,2- a ]pyrimidine to reduce metabolism mediated by aldehyde oxidase (AO) J. Med. Chem. 2011, 54, 7705-7712
27. Ghafourian, T.; Rashidi, M. R. Quantitative study of the structural requirements of phthalazine/quinazoline derivatives for interaction with human liver aldehyde oxidase Chem. Pharm. Bull. 2001, 49, 1066-1071
28. Magee, T. V.; Ripp, S. L.; Li, B.; Buzon, R. A.; Chupak, L.; Dougherty, T. J.; Finegan, S. M.; Girard, D.; Hagen, A. E.; Falcone, M. J.; Farley, K. A.; Granskog, K.; Hardink, J. R.; Huband, M. D.; Kamicker, B. J.; Kaneko, T.; Knickerbocker, M. J.; Liras, J. L.; Marra, A.; Medina, I.; Nguyen, T.-T.; Noe, M. C.; Obach, R. S.; O'Donnell, J. P.; Penzien, J. B.; Reilly, U. D.; Schafer, J. R.; Shen, Y.; Stone, G. G.; Strelevitz, T. J.; Sun, J.; Tait-Kamradt, A.; Vaz, A. D. N.; Whipple, D. A.; Widlicka, D. W.; Wishka, D. G.; Wolkowski, J. P.; Flanagan, M. E. Discovery of azetidinyl ketolides for the treatment of susceptible and multidrug resistant community-acquired respiratory tract infections J. Med. Chem. 2009, 52, 7446-7457